Research & Innovation

Driving improvement through discovery. Explore active studies, recruitment criteria, and network publications.

Active Studies

Current multi-centre studies open for recruitment in the South East.

NURTuRE Recruiting

Nephrotic Syndrome Biobank

Biobank Study UK Multi-centre

This multi-centre UK study is for children with nephrotic syndrome and is aiming to understand what causes the disease.

Visit Website ↗
VALIANT Recruiting

Pegcetacoplan in C3G & IC-MPGN

Phase 3 Trial International

This international multi-centre phase 3 study is assessing efficacy and safety of Pegcetacoplan in C3 glomerulopathy or immune-complex membranoproliverative glomerulonephritis (IC-MPGN).

View ClinicalTrials.gov ↗
ATTOMiC Recruiting

Access to Transplantation

Observational UK Multi-centre

This UK multi-centre study looks at barriers to kidney transplantation in children.

Contact for Info →
RaDaR Recruiting

Rare Renal Disease Registry

Ongoing All Centres

National registry for rare kidney diseases. Essential for long-term outcome monitoring and future trials.

View Inclusion Criteria →

Previous Studies

Completed trials and published outcomes.

PLUTO Completed

PlasmaLyte Fluid Trial

This trial was testing a specific type of intravenous fluid (PlasmaLyte) used as the main fluid in children immediately after a kidney transplant.

PREDNOS 2 Completed

Relapsing Nephrotic Syndrome

A large UK multi-centre study found that giving a daily low dose of prednisolone for 6 days to children with relapsing nephrotic syndrome at the time of an upper respiratory tract infection did not reduce the risk of them developing a relapse.

Read Results in JAMA Pediatrics ↗
HOTKID Completed

Blood Pressure in CKD

Investigated whether controlling blood pressure in children with chronic kidney disease to a lower level would help prevent cardiovascular damage. Results suggested a target blood pressure at the 50th percentile is optimal.

Read Results in The Lancet ↗
ECUSTEC Withdrawn

Eculizumab in STEC-HUS

A multi-centre UK trial to see if the complement-blocking drug, eculizumab, was effective in diarrhoea-associated or STEC-HUS. Funding was withdrawn part-way through because the numbers of cases of HUS reduced.

Network Publications

Incidence of AKI in secondary care hospitals: A network audit

Pediatric Nephrology, 2026 in planning

Abstract available on publication

Selected Other Publications

Demographics of childhood hypertension in the UK: a report from the Southeast England

Haseler E, Singh C, Newton J, Melhem N, Sinha MD.
J Hum Hypertens. 2023 Jul;37(7):554-559.

Read Paper ↗

Clinical practice guidelines standardisation of immunosuppressive and anti-infective drug regimens in UK paediatric renal transplantation: the harmonisation programme

Dudley J, Christian M, Andrews A, et al.
BMC Nephrol. 2021 Sep 16;22(1):312.

Read Paper ↗